NCT05456152View on ClinicalTrials.gov

Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia

PHASE3UnknownINTERVENTIONAL

Enrollment

358

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

February 28, 2025

Conditions

Chronic Insomnia

Interventions

DRUG

Sublingual Tablet

Sublingual zolpidem - 1 sublingual tablet 30 minutes before bed time.

Trial Locations (1)

Unknown

Investigational Site, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

EMS

INDUSTRY